• About Us
    • Contact Us
    • Login
    • ObGFirst
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • COVID-19
About Us Contact Us Login ObGFirst
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • COVID-19
Grand Rounds

Placenta Previa: How Accurate is the Second Trimester Internal Os Distance Measurement?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • Most cases of placenta previa and low-lying placenta seen on second trimester ultrasound will no longer be present on the follow-up third trimester scan
  • Jansen et al. (Ultrasound in Obstetrics & Gynecology, 2020) sought to assess the accuracy of the placental edge to internal os distance (IOD) measurement for the prediction of third trimester low-positioned placenta

METHODS:

  • Prospective cohort study
  • Participants
    • Pregnant women between 18 and 24 weeks
    • Undergoing TV ultrasound
    • Presence of low-positioned placenta
  • Study design
    • Low-positioned placenta: IOD <20 mm
      • Placenta previa: Placenta covering the internal os of the cervix | Low-lying placenta: Placenta within 20 mm
    • All women also underwent follow-up third trimester ultrasound scan
    • Relative risk (RR) for a low-positioned placenta in the third trimester was calculated for the following  
      • Placenta previa vs a low-lying placenta
      • Posterior vs anterior placenta
      • Positive vs negative history of cesarean delivery
    • Multilevel likelihood ratios for ranges of IOD in the prediction of a low-positioned placenta in the third trimester were calculated separately for anteriorly and posteriorly located placentae

RESULTS:

  • 958 women
  • Placental location at second trimester
    • Placentae were more frequently posterior (62.0%) vs anterior (38.0%)
  • 5.0% of women had low-positioned placenta that persisted into the third trimester

Persistence of Low-positioned Placenta in the Third Trimester

  • Placenta previa vs low-lying placenta at time of second trimester scan
    • Placenta previa: 20.4%
    • Low-lying placenta: 1.4%
    • RR 17.9 (95% CI, 8.9 to 36.0)
  • Posterior vs anterior placental location on second trimester scan 
    • Posterior: 6.4%
    • Anterior: 2.7%
    • RR 2.4 (95% CI, 1.2 to 4.9)
  • Women with vs without a history of cesarean
    • With previous cesarean: 13.3%
    • Without: 4.0%
    • RR 3.7 (95% CI, 1.9 to 7.2)

Cut-off Value of IOD in the Second Trimester to Identify All Cases of an Abnormally Located Placenta in the Third Trimester

  • For posterior placentae: 15.5 mm
  • For anterior placentae: -4.5 mm (4.5-mm overlap of the placental edge over the internal os of the cervix)

CONCLUSION:

  • A low-positioned placenta is more likely to persist into the third trimester if it is posteriorly located
  • The authors state that the current IOD threshold of 20 mm could potentially be reduced

…in posteriorly located placentae, an IOD of 15.5 mm in the second trimester is associated with a negligible risk for placenta previa or low‐lying placenta in the third trimester

…for anteriorly located placentae, even one covering the internal os of the cervix by up to 4.5 mm in the second trimester is likely to resolve by the third trimester

Using these cut‐off values, the number of unnecessary follow‐up ultrasound examinations could be substantially decreased, notwithstanding the current advice to rescan all women with a low‐positioned placenta

Learn More – Primary Sources:

Follow‐up ultrasound in second‐trimester low‐positioned anterior and posterior placentae: prospective cohort study

Now You Can Get ObG Clinical Research Summaries Direct to Your Phone, with ObGFirst

ObGFirst® – Try It Free! »

image_pdfFavoriteLoadingFavorite
< Previous
All Grand Rounds Posts
Next >

Related ObG Topics:

Placenta Previa – Nomenclature, Diagnosis and Clinical Management
Vaginal Delivery or Cesarean Section for a Low-Lying Placenta?
Vasa Previa: Prevalence and Risk Factors
Is Placental Location Other than Previa Linked to Adverse Perinatal Outcomes?

Sections

  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • Grand Rounds
  • My Bookshelf
  • COVID-19

Are you an
ObG Insider?

Get specially curated clinical summaries delivered to your inbox every week for free

  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site